A re-evaluation of kava (Piper methysticum)
Open Access
- 15 August 2007
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 64 (4), 415-417
- https://doi.org/10.1111/j.1365-2125.2007.02932.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Safety of ethanolic kava extract: Results of a study of chronic toxicity in ratsPhytomedicine, 2006
- Akute Hepatitis durch Kava-Kava und Johanniskraut: immun-vermittelter Mechanismus?Deutsche Medizinische Wochenschrift (1946), 2006
- In Vitro Cytotoxicity of Nonpolar Constituents from Different Parts of Kava Plant (Piper methysticum)Journal of Agricultural and Food Chemistry, 2006
- Potential for interaction of kava and St. John's wort with drugsJournal of Ethnopharmacology, 2005
- Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.)Journal of Ethnopharmacology, 2004
- DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23Drug Metabolism and Disposition, 2004
- Enhanced cognitive performance and cheerful mood by standardized extracts ofPiper methysticum(Kava-kava)Human Psychopharmacology: Clinical and Experimental, 2004
- Kava–Kava administration reduces anxiety in perimenopausal womenMaturitas, 2003
- Kava extract versus placebo for treating anxietyEmergencias, 2003
- Piper methysticum (Kava) in der Diskussion: Betrachtungen zu Qualitat, Wirksamkeit und Unbedenklichkeit***Wiener Medizinische Wochenschrift, 2002